197 related articles for article (PubMed ID: 24698514)
21. Nodular Arteriolar Hyalinosis as Histopathologic Hallmark of Calcineurin Inhibitor Nephrotoxicity: Does It Always Have the Same Meaning?
Vázquez LC; González AP; Juega J; Hernández-Gallego A; López D; Cañas L; Bancu I; Bonet J; Lauzurica R
Transplant Proc; 2015 Oct; 47(8):2357-60. PubMed ID: 26518926
[TBL] [Abstract][Full Text] [Related]
22. Urinary microbiome associated with chronic allograft dysfunction in kidney transplant recipients.
Wu JF; Muthusamy A; Al-Ghalith GA; Knights D; Guo B; Wu B; Remmel RP; Schladt DP; Alegre ML; Oetting WS; Jacobson PA; Israni AK
Clin Transplant; 2018 Dec; 32(12):e13436. PubMed ID: 30372560
[TBL] [Abstract][Full Text] [Related]
23. Transcriptome changes in renal allograft protocol biopsies at 3 months precede the onset of interstitial fibrosis/tubular atrophy (IF/TA) at 6 months.
Scherer A; Gwinner W; Mengel M; Kirsch T; Raulf F; Szustakowski JD; Hartmann N; Staedtler F; Engel G; Klupp J; Korn A; Kehren J; Haller H
Nephrol Dial Transplant; 2009 Aug; 24(8):2567-75. PubMed ID: 19398767
[TBL] [Abstract][Full Text] [Related]
24. Proteomic Characterization of Urinary Extracellular Vesicles from Kidney-Transplanted Patients Treated with Calcineurin Inhibitors.
Carreras-Planella L; Juega J; Taco O; Cañas L; Franquesa M; Lauzurica R; Borràs FE
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066346
[TBL] [Abstract][Full Text] [Related]
25. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
26. Impact of calcineurin-inhibitor conversion to mTOR inhibitor on renal allograft function in a prednisone-free regimen.
Chhabra D; Alvarado A; Dalal P; Leventhal J; Wang C; Sustento-Reodica N; Najafian N; Skaro A; Levitsky J; Mas V; Gallon L
Am J Transplant; 2013 Nov; 13(11):2902-11. PubMed ID: 24007570
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of everolimus in chronic allograft nephropathy.
Das U; Dakshinamurty KV
Saudi J Kidney Dis Transpl; 2013 Sep; 24(5):910-6. PubMed ID: 24029254
[TBL] [Abstract][Full Text] [Related]
28. ARFI-based tissue elasticity quantification and kidney graft dysfunction: first clinical experiences.
Stock KF; Klein BS; Cong MT; Regenbogen C; Kemmner S; Büttner M; Wagenpfeil S; Matevossian E; Renders L; Heemann U; Küchle C
Clin Hemorheol Microcirc; 2011; 49(1-4):527-35. PubMed ID: 22214724
[TBL] [Abstract][Full Text] [Related]
29. Orthogonal Comparison of Molecular Signatures of Kidney Transplants With Subclinical and Clinical Acute Rejection: Equivalent Performance Is Agnostic to Both Technology and Platform.
Kurian SM; Velazquez E; Thompson R; Whisenant T; Rose S; Riley N; Harrison F; Gelbart T; Friedewald JJ; Charette J; Brietigam S; Peysakhovich J; First MR; Abecassis MM; Salomon DR
Am J Transplant; 2017 Aug; 17(8):2103-2116. PubMed ID: 28188669
[TBL] [Abstract][Full Text] [Related]
30. Expression of fibrosis-related genes in human renal allografts with interstitial fibrosis and tubular atrophy.
Nogare AL; Dalpiaz T; Pedroso JA; Montenegro RM; Pegas KL; Veronese FV; Gonçalves LF; Manfro RC
J Nephrol; 2013; 26(6):1179-87. PubMed ID: 23661587
[TBL] [Abstract][Full Text] [Related]
31. Evolution of allograft fibrosis and function in kidney transplant recipients: a retrospective analysis of stable patients under CNI and mTORi.
Becker LE; Weritz B; Yi X; Gross-Weissmann ML; Waldherr R; Zeier M; Sommerer C
Transpl Int; 2015 May; 28(5):553-64. PubMed ID: 25630217
[TBL] [Abstract][Full Text] [Related]
32. Molecular Profile of Mitochondrial Dysfunction in Kidney Transplant Biopsies Is Associated With Poor Allograft Outcome.
Zepeda-Orozco D; Kong M; Scheuermann RH
Transplant Proc; 2015; 47(6):1675-82. PubMed ID: 26293032
[TBL] [Abstract][Full Text] [Related]
33. Abatacept as rescue immunosuppression after calcineurin inhibitor treatment failure in renal transplantation.
Badell IR; Karadkhele GM; Vasanth P; Farris AB; Robertson JM; Larsen CP
Am J Transplant; 2019 Aug; 19(8):2342-2349. PubMed ID: 30768841
[TBL] [Abstract][Full Text] [Related]
34. Molecular and structural consequences of early renal allograft injury.
Baboolal K; Jones GA; Janezic A; Griffiths DR; Jurewicz WA
Kidney Int; 2002 Feb; 61(2):686-96. PubMed ID: 11849412
[TBL] [Abstract][Full Text] [Related]
35. Kidney injury molecule-1 expression in human kidney transplants with interstitial fibrosis and tubular atrophy.
Nogare AL; Veronese FV; Carpio VN; Montenegro RM; Pedroso JA; Pegas KL; Gonçalves LF; Manfro RC
BMC Nephrol; 2015 Feb; 16():19. PubMed ID: 25884518
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA profiles in allograft tissues and paired urines associate with chronic allograft dysfunction with IF/TA.
Scian MJ; Maluf DG; David KG; Archer KJ; Suh JL; Wolen AR; Mba MU; Massey HD; King AL; Gehr T; Cotterell A; Posner M; Mas V
Am J Transplant; 2011 Oct; 11(10):2110-22. PubMed ID: 21794090
[TBL] [Abstract][Full Text] [Related]
37. Discovery and cross-validation of peripheral blood and renal biopsy gene expression signatures from ethnically diverse kidney transplant populations.
Ventura CG; Whisenant T; Gelbart T; David DSR; Agena F; Salomon DR; David-Neto E; Kurian SM
Am J Transplant; 2019 Dec; 19(12):3356-3366. PubMed ID: 31152474
[TBL] [Abstract][Full Text] [Related]
38. Failure of Calcineurin Inhibitor (Tacrolimus) Weaning Randomized Trial in Long-Term Stable Kidney Transplant Recipients.
Dugast E; Soulillou JP; Foucher Y; Papuchon E; Guerif P; Paul C; Riochet D; Chesneau M; Cesbron A; Renaudin K; Dantal J; Giral M; Brouard S
Am J Transplant; 2016 Nov; 16(11):3255-3261. PubMed ID: 27367750
[TBL] [Abstract][Full Text] [Related]
39. Immune function assay (ImmuKnow) as a predictor of allograft rejection and infection in kidney transplantation.
He J; Li Y; Zhang H; Wei X; Zheng H; Xu C; Bao X; Yuan X; Hou J
Clin Transplant; 2013; 27(4):E351-8. PubMed ID: 23682828
[TBL] [Abstract][Full Text] [Related]
40. Suppressed calcineurin-dependent gene expression identifies lung allograft recipients at increased risk of infection.
Greenland JR; Chong T; Wang AS; Martinez E; Shrestha P; Kukreja J; Hays SR; Golden JA; Singer JP; Tang Q
Am J Transplant; 2018 Aug; 18(8):2043-2049. PubMed ID: 29673076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
